Contagion® will be heading to Amsterdam, Netherlands, on Saturday, April 13, 2019, to report on the annual European Congress of Clinical Microbiology and Infectious Diseases conference.
Contagion® will be heading to Amsterdam, Netherlands, on Saturday, April 13, 2019, to report on the annual
As a trusted source in the realm of infectious disease, the editorial team of Contagion® strives to consistently report on new developments in the field. Some of our recent coverage includes a feature on the on the
What’s on the docket for the ECCMID conference this year?
Coverage will be focused on antimicrobial agents in the pipeline; treating health care-associated infections; the use of technology in infection management and control; the application of bacteriophages; advances in fighting antimicrobial resistance; plus, the results of several phase 3 clinical studies.
Additional coverage will focus on advances in the prevention, management, and treatment of various infections, such as Clostridium difficile, chronic bone and joint infections, and community-acquired pneumonia, among others. Contagion® will also be reporting the latest data on novel agents and the latest news in drug delivery systems.
In keeping with our dedication to providing our readership with the most timely and relevant content to support their practices and improve patient outcomes, Contagion® editors will provide exclusive written coverage, along with engaging video interviews with several key opinion leaders on important issues and advancements made in the realm of infectious disease.
Some of the presentations that we will cover in the upcoming week include 1 from Jean-Michel Molina, MD, PhD, from the University of Paris Diderot, who will deliver a keynote lecture on biomedical prophylaxis of HIV and other sexually transmitted infections; and from Caroline Lefeuvre, of Angers University Hospital, discussing urinary HPV DNA testing. We will also speak with Jose A. Vazquez, MD, FACP, FIDSA, with the Medical College of Georgia at Augusta University, on his case report from the FURI study on oral ibrexafungerp for refractory fungal diseases; and Les Tari, PhD, senior vice president of research at Cidara, on Cloudbreak, a novel approach for the treatment and prevention of influenza.
Tom van der Poll, MD, PhD, from Amsterdam UMC, University of Amsterdam, will deliver a symposia talk on sepsis; and Steven Y. C. Tong, PhD, with the Menzies School of Health Research in Darwin, Australia, will speak about the results of the CAMERA2 trial on combination antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteremia.
Going to the conference? Be sure to say hello between interviews or sessions; we'll be there!
Not going to the conference? Be sure to sign up for our conference updates.
Also, be sure to follow us on
